Investors see a biotech comeback in 2024 as rates fall, deal-making picks up. Stocks to watch
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. A look at what 2024 might
Read More
Exelixis Inc
Stocks making the biggest moves premarket: Johnson & Johnson, FedEx, Zions and more
FedEx's shares gained more than 2% before the bell after announcing a dividend hike and a corporate reorganization. Source link
Read More
Analysts love these AI stocks with big upside potential to play the ChatGPT-driven artificial intelligence craze
With the current hype around ChatGPT, investors need to be able to distinguish an exciting AI opportunity from an overhyped
Read More
These companies are cheap, have strong balance sheets, and analysts love them
The current market backdrop could present an opportune moment for long-term investors. Source link
Read More